Similar articles

• Atopic hypersensitivity to L-asparaginase. Resistance to immunosuppression.

  Khan A, Hill JM. Khan A, et al. Int Arch Allergy Appl Immunol. 1971;40(3):463-9. doi: 10.1159/000230429. Int Arch Allergy Appl Immunol. 1971. PMID: 4993767 No abstract available.
• [L-Asparaginase in the treatment of acute leukemia].

  Mathé G, Amiel JL, Clarysse A, Hayat M, Schwarzenberg L, Schneider M. Mathé G, et al. Sem Hop. 1970 Apr 8;46(17):1135-40. Sem Hop. 1970. PMID: 4315231 French. No abstract available.
• Immunological responses to L-asparaginase.

  Peterson RG, Handschumacher RE, Mitchell MS. Peterson RG, et al. J Clin Invest. 1971 May;50(5):1080-90. doi: 10.1172/JCI106579. J Clin Invest. 1971. PMID: 4101590 Free PMC article. Clinical Trial.
• [L-asparaginase--first specific cytostatic].

  Marquardt H. Marquardt H. Arzneimittelforschung. 1968 Nov;18(11):1380-6. Arzneimittelforschung. 1968. PMID: 4885156 Review. German. No abstract available.
• L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasms.

  Haskell CM. Haskell CM. Cancer Treat Rep. 1981;65 Suppl 4:57-9. Cancer Treat Rep. 1981. PMID: 7049381 Review.